Pancreatic cancer research matures.
Nelson
Nancy J
NJ
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood*; D035843:Biomedical Research / Q000639:trends; D015195:Drug Design; D006801:Humans; D008403:Mass Screening / Q000379:methods; D009154:Mutation; D009363:Neoplasm Proteins / Q000097:blood*; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000401:mortality / Q000517:prevention & control; D011518:Proto-Oncogene Proteins / Q000235:genetics; D016283:Proto-Oncogene Proteins p21(ras); D012307:Risk Factors; D015996:Survival Rate; D014481:United States / Q000453:epidemiology; D018631:ras Proteins / Q000235:genetics
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; C117307:KRAS protein, human; D009363:Neoplasm Proteins; D011518:Proto-Oncogene Proteins; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins